Alzheimers Medication

Alzheimer’s disease is defined as a progressive brain disorder that gradually destroys a person’s memory and ability to learn, reason, make judgments, communicate and carry out daily activities. As Alzheimer’s progresses, individuals may also experience changes in personality and behavior, such as anxiety, suspiciousness or agitation, as well as delusions or hallucinations.

This disease has no single cause. There seems to be correlation with increasing age and a family history of the disease.

There is currently no cure for Alzheimer’s. Research has shown that effective care and support can improve quality of life for individuals and their caregivers over the course of the disease from diagnosis to the end of life.

Alzheimer’s is the most common form of dementia, a group of conditions that all gradually destroy brain cells and lead to progressive decline in mental function. Vascular dementia, another common form, results from reduced blood flow to the brain’s nerve cells. In some cases, Alzheimer’s disease and vascular dementia can occur together in a condition called “mixed dementia.” Other causes of dementia include frontotemporal dementia, dementia with Lewy bodies, Creutzfeldt-Jakob disease and Parkinson’s disease.

Alzheimer’s disease advances at widely different rates. People with Alzheimer’s die an average of four to six years after diagnosis, but the duration of the disease can vary from three to 20 years. The areas of the brain that control memory and thinking skills are affected first, but as the disease progresses, cells die in other regions of the brain. Eventually, the person with Alzheimer’s will need complete care. If the individual has no other serious illness, the loss of brain function itself will cause death.

Progression of this disease can be grouped into:

Early-stage, the early part of Alzheimer’s disease when problems with memory, thinking and concentration may begin to appear in a doctor’s interview or medical tests. Individuals in the early-stage typically need minimal assistance with simple daily routines. At the time of diagnosis, an individual is not necessarily in the early stage of the disease; he or she may have progressed beyond the early stage.

The term early-onset refers to Alzheimer’s that occurs in a person under age 65. Early-onset individuals may be employed or have children still living at home. Issues facing families include ensuring financial security, obtaining benefits and helping children cope with the disease. People who have early-onset dementia may be in any stage of dementia – early, middle or late.

Treating Alzheimer’s

Medications approved by the FDA may temporarily delay the memory decline for some individuals but none is known to stop the degeneration of the brain cells. It is also known that the longer an individual stays mentally active the the onset seems to be put off to later years

New researches may offer promising options to slow or even reverse the damage of the nerve cells

This brings me to a scientist who may have found a solution or just another aid to improving the quality of life in Alzheimer’s although he makes no claims.

Dr. Alexander Schauss, Creator of Feed My Brain. As you proceed, ask yourself?

Could you benefit from a natural product that supports short term and long term memory? Could you benefit from a product that supports the increase in IQ? Could you benefit from a product that supports mental focus and concentration? If you answered “yes” to any of the above questions, then you and your children may need “Feed My Brain”, SMART NUTRITION FOR THE MIND. F.M.B. is a DRUG FREE, Dietary supplement that contains over 50 natural ingredients, including 14 learning nutrients and natural compounds found in fruits and vegetables that are building blocks for the human brain. The nutrients in F.M.B. help support mental energy and help support Neurotransmitters that help to enhance brain function. These very things found wanting in Alzheimer’s and any other brain defects.